1-20 of 31
Fatiha Chermat
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I/II Clinical Trial Evaluating Azacitidine + Venetoclax + Donor Lymphocyte Infusion in Post-Transplant Relapse Myelodysplastic Syndromes and Acute Myeloid Leukemia: Preliminary Results of Ventograft, a GFM Study

Thomas Cluzeau, Marie Sebert, Michael Loschi, Lionel Ades, Sylvain Thepot, Martin Carre, Nicolas Duployez, Rosa Sapena, Fatiha Chermat, Claude Preudhomme, Pierre Fenaux, Marie Robin
Journal: Blood
Blood (2023) 142 (Supplement 1): 3246.
https://doi.org/10.1182/blood-2023-178021
Published: 2023
Journal Articles

FLT3 Ligand Kinetic Profile Predicts Response to Treatment and Event-Free Survival (EFS) in Adults with High-Risk MDS/CMML Receiving CPX-351: A GFM Study

Pierre Peterlin, Joëlle Gaschet, Pascal Turlure, Marie-Pierre Gourin, Pierre-Yves Dumas, Sylvain Thepot, Ana Berceanu, Sophie Park, Marie Anne Hospital, Thomas Cluzeau, Jose-Miguel Torregrosa-Diaz, Louis Drevon, Rosa Sapena, Fatiha Chermat, Sophie Dimicoli-Salazar, Maxime Jullien, Pierre Fenaux, Patrice Chevallier
Journal: Blood
Blood (2023) 142 (Supplement 1): 6469.
https://doi.org/10.1182/blood-2023-173741
Published: 2023
Journal Articles

A Phase II Study of Single Agent Aspacytarabine (BST-236) in Adults Unfit for Intensive Chemotherapy with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) or Higher Risk Myelodysplastic Syndromes (R/R HR MDS)

Marie Anne Hospital, Thomas Cluzeau, Alice Garnier, Giovanni Marconi, Emmanuelle Tavernier, Sylvain Thepot, Aspasia Stamatoullas, Cristina Papayannidis, Sophie Park, Noemie Bigot, Lamya AIT SI Selmi, Fatiha Chermat, Sylvie Chevret, Pierre Fenaux
Journal: Blood
Blood (2023) 142 (Supplement 1): 2923.
https://doi.org/10.1182/blood-2023-185609
Published: 2023
Journal Articles

Impact of Arsenic Trioxide in the Treatment of Higher Risk Acute Promyelocytic Leukemia

Audrey Da Rocha, Bruno Cassinat, Mael Heiblig, Christian Recher, Sarah Bertoli, Caroline Bonmati, Gabrielle Roth-Guepin, Anne Zilliox, Marie Laloi, Mathilde Hunault, Céline Berthon, Nicolas Duployez, Christophe Willekens, Maria Pilar Gallego Hernanz, Marlene Ochmann, Thomas Cluzeau, Fatiha Chermat, Alexis Caulier, Emmanuel Raffoux, Pierre Fenaux, Jean Pierre Marolleau, Lionel Ades, Delphine Lebon
Journal: Blood
Blood (2023) 142 (Supplement 1): 1471.
https://doi.org/10.1182/blood-2023-174446
Published: 2023
Journal Articles

Safety and Efficacy of Mitapivat in Adult Patients with Erythrocyte Membranopathies (SATISFY)

Andreas Glenthoej, Eduard J. Van Beers, Richard van Wijk, Minke A.E. Rab, Evelyn Groot, Niels G Vejlstrup, Selma K Bendtsen, Nina Toft, Jesper Petersen, Jens Helby, Fatiha Chermat, Pierre Fenaux, Kevin H.M. Kuo
Journal: Blood
Blood (2023) 142 (Supplement 1): 1085.
https://doi.org/10.1182/blood-2023-173147
Published: 2023
Journal Articles

Efficacy and Safety of Luspatercept +/- Erythropoiesis-Stimulating Agent (ESA) in Patients with Myelodysplastic Syndromes with Ring Sideroblasts (MDS-RS): A French Multicenter Prospective Real-Life Registry

Thibault Comont, Maud D'Aveni, Laurence Schenone, Jose Miguel Torregrosa-Díaz, Lorea Aguinaga, Juan Pardo, Marie Sebert, Sorin Visanica, Clemence Santana, Lenaig Le Clech, Aspasia Stamatoullas, Sylvain Thepot, Etienne Daguindau, Guillaume Beziat, Teresa Botin, Sophie Dimicoli, Sophie Park, Etienne Paubelle, Bohrane Slama, Lise Willems, Houria Debarri, Emmanuel Gyan, Claire Calmettes, Odile Rauzy, Fatiha Chermat, Michaela Fontenay, Lionel Ades, Pierre Fenaux
Journal: Blood
Blood (2023) 142 (Supplement 1): 6471.
https://doi.org/10.1182/blood-2023-177787
Published: 2023
Journal Articles

Dynamics of Mortality and Transformation Risk within Different Risk Groups of Patients with Myelodysplastic Syndromes Stratified According to the IPSS-R - Comparison of Treated and Untreated Patients and Consequences for the Description of Risk Categories

Michael Pfeilstocker, Heinz Tuechler, Lionel Ades, Jaroslav Cermak, Fatiha Chermat, Matteo G. Della Porta, Pierre Fenaux, Guillermo Garcia-Manero, Ulrich Germing, Detlef Haase, Andrea Kuendgen, Michael Luebbert, Silvia Maria Meira Magalhaes, Luca Malcovati, Yasushi Miyazaki, Guillermo Sanz, Valeria Santini, Mikkael A. Sekeres, Matthew J Walter, Peter Valent, Peter L Greenberg
Journal: Blood
Blood (2022) 140 (Supplement 1): 6976–6978.
https://doi.org/10.1182/blood-2022-158671
Published: 2022
Journal Articles

Molecular Response Analysis By High Throughput Sequencing in Higher Risk Myelodysplastic Syndrome (HR-MDS) Treated Intensively with CPX-351

Yannick Le Bris, Simon Bouzy, Audrey Ménard, Pascal Turlure, Patrice Chevallier, Marie-Pierre Gourin, Pierre-Yves Dumas, Sylvain Thepot, Anna Berceanu, Sophie Park, Marie-Anne Hospital, Thomas Cluzeau, Jose-Miguel Torregrosa Diaz, Louis Devron, Rosa Sapena, Fatiha Chermat, Sophie Dimicoli Salazar, Marie C Béné, Pierre Fenaux, Pierre Peterlin
Journal: Blood
Blood (2022) 140 (Supplement 1): 9821–9823.
https://doi.org/10.1182/blood-2022-162278
Published: 2022
Journal Articles

Ivosidenib Monotherapy Is Effective in Patients with IDH1 Mutated Myelodysplastic Syndrome (MDS): The Idiome Phase 2 Study By the GFM Group

Marie Sebert, Thomas Cluzeau, Odile Beyne Rauzy, Aspasia Stamatoulas Bastard, Sophie Dimicoli-Salazar, Sylvain Thepot, Pierre Peterlin, Sophie Park, Marie-Pierre Gourin, Oana Brehar, Cécile Bally, Sébastien Maury, Gaelle Fossard, Lamya Ait Si Selmi, Cendrine Chaffaut, Emmanuelle Clappier, Raphael Itzykson, Fatiha Chermat, Sylvie Chevret, Pierre Fenaux, Lionel Ades
Journal: Blood
Blood (2021) 138 (Supplement 1): 62.
https://doi.org/10.1182/blood-2021-146932
Published: 2021
Journal Articles

Enasidenib (ENA) Is Effective in Patients with IDH2 Mutated Myelodysplastic Syndrome (MDS) : The Ideal Phase 2 Study By the GFM Group

Lionel Ades, Sophie Dimicoli-Salazar, Marie Sebert, Thomas Cluzeau, Aspasia Stamatoulas Bastard, Kamel Laribi, Gaelle Fossard, Raphael Itzykson, Odile Beyne Rauzy, Alice Garnier, Silke Gloaguen, Norbert Vey, Caroline Le Jeune, Aristoteles Giagounidis, Emmanuel Gyan, Baptiste Perard, Sylvain Thepot, Mario Ojeda, Fatiha Chermat, Kristell Desseaux, Emmanuelle Clappier, Sylvie Chevret, Uwe Platzbecker, Pierre Fenaux
Journal: Blood
Blood (2021) 138 (Supplement 1): 63.
https://doi.org/10.1182/blood-2021-147898
Published: 2021
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (allo HSCT) in Patients with IPSS Low or Intermediate-1 Myelodysplastic Syndrome (MDS): A Prospective Multicenter Phase II Study Based on Donor Availability By the GFM & SFGM-TC "MDS-ALLO-Risk"

Marie Sebert, Cendrine Chaffaut, Sylvain Thepot, Corentin Orvain, Thomas Cluzeau, Michael Loschi, Pierre Peterlin, Patrice Chevallier, Maud d'Aveni, Marie-Thérèse Rubio, Odile Beyne Rauzy, Anne Huynh, Amandine Charbonnier, Nathalie Fegueux, Gaelle Fossard, Stephanie N'guyen-Quoc, Sophie Park, Rosa Sapena, Fatiha Chermat, Lionel Ades, Sylvie Chevret, Pierre Fenaux, Marie Robin
Journal: Blood
Blood (2021) 138 (Supplement 1): 1842.
https://doi.org/10.1182/blood-2021-146846
Published: 2021
Journal Articles

A Phase II Study of the Efficacy and Tolerance of Azacytidine (AZA) in Steroid Dependent/Refractory Systemic Autoimmune and Inflammatory Disorders (SAID) Associated with MDS or CMML (GFM- AZA-SAID -trial)

Arsène Mékinian, Lin-Pierre Zhao, Kristell Desseaux, Rose Rose, Laurent Pascal, Pierre Peterlin, Thibault Comont, Alexandre Maria, Louis Terriou, Maud d'Aveni, Marie-Pierre Gourin, Norbert Vey, Odile bayne Rouzy, Sophie Dimicoli Salazar, Anne Banos, Stefan Wickenhauser, Benoit De Renzis, Eric Durot, Shanti Ame, Laurent Voillat, Fatiha Chermat, Anne Vekhoff, Karine Lemaire, Vincent Jachiet, Sylvie Chevret, Lionel Ades, Olivier Fain, Pierre Fenaux
Journal: Blood
Blood (2021) 138 (Supplement 1): 3697.
https://doi.org/10.1182/blood-2021-150904
Published: 2021
Journal Articles

CPX 351 As First Line Treatment in Higher Risk MDS. a Phase II Trial By the GFM

Pierre Peterlin, Pascal Turlure, Patrice Chevallier, Marie-Pierre Gourin, Pierre-Yves Dumas, Sylvain Thepot, Anna Berceanu, Sophie Park, Marie Anne Hospital, Thomas Cluzeau, Jose Miguel Torregrosa Diaz, Louis Devron, Sylvie Chevret, Marie C Bene, Yannick Le Bris, Rosa Sapena, Fatiha Chermat, Sophie Dimicoli-Salazar, Pierre Fenaux
Journal: Blood
Blood (2021) 138 (Supplement 1): 243.
https://doi.org/10.1182/blood-2021-145123
Published: 2021
Journal Articles

Efficacy and Safety of Bemcentinib in Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Failing Hypomethylating Agents

Anne Sophie Kubasch, Pierre Peterlin, MD, Thomas Cluzeau, MD PhD, Katharina S. Götze, Katja Sockel, MD, Raphael Teipel, MD, Madlen Jentzsch, MD, Sabine Kayser, MD, Habiba Attalah, Fatiha Chermat, Silke Gloaguen, Msc, Katja Jersemann, Dorothea Schipp, Aristoteles Giagounidis, Stuart McPherson, BSc, Irene Tirado-González, Arjan van de Loosdrecht, MD PhD, Pierre Fenaux, MD PhD, Uwe Platzbecker, Hind Medyouf, Lionel Ades, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-140240
Published: 2020
Journal Articles

Red Blood Cell Transfusion Burden in Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS): A Retrospective Multicenter Study By the Groupe Francophone Des Myélodysplasies (GFM)

Claire Jouzier, Amina Cherait, Pascale Cony-Makhoul, MD, Sylvain Thepot, MD, Thomas Cluzeau, MD PhD, Aspasia Stamatoulas Bastard, MD, Pierre Peterlin, MD, Agnes Guerci Bresler, MD, Sophie Dimicoli-Salazar, MD, Gian-Matteo Pica, MD, Stephane Cheze, MD, Clémence Santana, MD, Fatiha Chermat, Pierre Fenaux, MD PhD, Sophie Park, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-138722
Published: 2020
Journal Articles

A Molecular-Based Response Prediction Model to Romiplostim in Patients with Lower-Risk Myelodysplastic Syndrome and Severe Thrombocytopenia

Anne Sophie Kubasch, Aristoteles Giagounidis, Georgia Metzgeroth, Anna Jonasova, MD PhD, Regina Herbst, MD, Jose Miguel Torregrosa Diaz, Benoit De Renzis, MD, Katharina S. Götze, Marie-Luise Huetter-Kroenke, MD, Marie-Pierre Gourin, Bohrane Slama, MD, Sophie Dimicoli-Salazar, MD, Pascale Cony-Makhoul, MD, Kamel Laribi, MD, Sophie Park, MD PhD, Katja Jersemann, Dorothea Schipp, Klaus H. Metzeler, MD, Oliver Tiebel, MD, Katja Sockel, MD, Silke Gloaguen, Msc, Anna Mies, Fatiha Chermat, Christian Thiede, MD, Rosa Sapena, Richard F. Schlenk, Pierre Fenaux, MD PhD, Uwe Platzbecker, Lionel Ades, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-139291
Published: 2020
Journal Articles

Decitabine Versus Hydroxyurea for Advanced Proliferative CMML: Results of the Emsco Randomized Phase 3 Dacota Trial

Raphael Itzykson, MD PhD, Valeria Santini, Cendrine Chaffaut, Ades Lionel, Sylvain Thepot, MD, Aristoteles Giagounidis, Margot Morabito, Nathalie Droin, Michael Luebbert, Rosa Sapena, Stanislas Nimubona, MD, Jean E. Goasguen, MD PhD, Eric Wattel, MD PhD, Gina Zini, MDPhD, Jose Miguel Torregrosa Diaz, Ulrich Germing, Anna Maria Pelizzari, Sophie Park, MD PhD, Nadja Jaekel, Georgia Metzgeroth, Francesco Onida, MD, Robert Navarro, Andrea Patriarca, MD, Aspasia Stamatoulas Bastard, MD, Martin Puttrich, Sandra Mossuto, Eric Solary, MD PhD, Silke Gloaguen, Msc, Sylvie Chevret, MD PhD, Fatiha Chermat, Uwe Platzbecker, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 53–54.
https://doi.org/10.1182/blood-2020-138680
Published: 2020
Journal Articles

Very Long Term Follow up a Phase II Study of Post-Remission Subcutaneous (SC) Azacitidine (AZA) in Patients with AML Post-MDS or Higher-Risk (HR) MDS

Amina Cherait, Thorsten Braun, MD PhD, Krimo Bouabdallah, MD, Denis Caillot, Agnès Guerci, MD PhD, Emmanuel Raffoux, MD, Jean Pierre Marolleau, Cecile Pautas, MD, Anne Banos, MD, Chantal Himberlin, MD, Anne Laure Taksin, Arnaud Pigneux, MD PhD, Xavier Thomas, MD PhD, Norbert Vey, MD, Sylvie Chevret, MDPhD, Herve Dombret, MD PhD, Fatiha Chermat, Lionel Ades, MDPhD, Claude Gardin, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-137012
Published: 2020
Journal Articles

Eltrombopag in Chronic Myelomonocytic Leukemia (CMML) with Severe Thrombocytopenia: Final Results of a Multicenter Phase II Study

Florence Rabian, MD, Jérôme Lambert, Daniela Barbieri, Berengere Gruson, MD, Sylvain Thepot, MD, Thorsten Braun, MD PhD, Norbert Vey, MD, Jacques Delaunay, MD, Laurence Legros, PhD MD, Julie Lejeune, Anouk Walter-petrich, Rosa Sapena, Nathalie Droin, PhD, Fatiha Chermat, Francoise Porteu, Daniel Lusina, Lionel Ades, MDPhD, Eric Solary, MD PhD, Pierre Fenaux, MDPhD, Raphael Itzykson, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-137469
Published: 2020
Journal Articles

APR-246 Combined with Azacitidine (AZA) in TP53 Mutated Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). a Phase 2 Study By the Groupe Francophone Des Myélodysplasies (GFM)

Thomas Cluzeau, MD PhD, Marie Sebert, MD, Ramy Rahmé, MD, Stefania Cuzzubbo, Anouk Walter-petrich, Jacqueline Lehmann che, Pierre Peterlin, Blandine Beve, Habiba Attalah, Fatiha Chermat, Elsa Miekoutima, Odile Beyne-Rauzy, Christian Recher, MD PhD, Aspasia Stamatoullas, MD, Lise Willems, MD, Emmanuel Raffoux, MD, Céline Berthon, MD PhD, Bruno Quesnel, Antoine Carpentier, David A Sallman, MD, Sylvie Chevret, MD PhD, Lionel Ades, MD PhD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 677.
https://doi.org/10.1182/blood-2019-125579
Published: 2019